PMID: 9557719Apr 29, 1998Paper

Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection

Journal of Virology
S J PolyakD R Gretch

Abstract

To study hepatitis C virus (HCV) genetic mutation during interferon (IFN) therapy, the temporal changes in HCV quasispecies heterogeneity were compared before and after treatment for nine patients infected with HCV genotype 1, including four nonresponders, four responders who relapsed after therapy, and one responder who experienced a breakthrough of viremia during therapy. Nine untreated patients with an average time between specimens of 8.4 years served as controls. Sequences from the second envelope glycoprotein gene hypervariable region 1 (HVR1) and the putative IFN sensitivity-determining region (ISDR) of the nonstructural NS5A gene were analyzed by heteroduplex mobility assays and nucleotide sequencing. A strong positive correlation was found between the percent change in a heteroduplex mobility ratio (HMR) and percent change in nucleotide sequence (r = 0.941, P < 0.001). The rate of fixation of mutations in the HVR1 was significantly higher for IFN-treated patients than for controls (6.97 versus 1.31% change in HMR/year; P = 0.02). Similarly, a higher rate of fixation of mutations was observed in the ISDR for IFN-treated patients than for untreated controls, although the result was not significant (1.45 versus 0.15 amino...Continue Reading

References

Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J WeinerK A Crawford
Aug 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K YoshiokaT Morishima
Sep 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S OkadaS Mishiro
Feb 28, 1991·Biochemical and Biophysical Research Communications·M HijikataK Shimotohno
Nov 30, 1989·The New England Journal of Medicine·G L DavisUNKNOWN Hepatitis Interventional Therapy Group
Nov 30, 1989·The New England Journal of Medicine·A M Di BisceglieJ H Hoofnagle
Dec 18, 1986·The New England Journal of Medicine·J H HoofnagleE A Jones
Nov 1, 1993·Journal of Gastroenterology and Hepatology·A TsubotaH Kumada
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·P FarciR H Purcell
Jan 1, 1994·Intervirology·S IinoK Yasuda
Jul 1, 1995·Journal of Virology·Y TanjiK Shimotohno
Jul 1, 1996·Journal of Medical Virology·R P González-PeraltaJ Y Lau
Mar 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S ZeuzemW K Roth
Mar 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D Herion, J H Hoofnagle
Jul 18, 1997·Biochemical and Biophysical Research Communications·A TanimotoR Padmanabhan
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases

❮ Previous
Next ❯

Citations

Jul 7, 2001·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·C FornaiM Bendinelli
Jun 13, 2002·The Journal of Biological Chemistry·Anna NadalJordi Gómez
Mar 26, 2003·Cell Death and Differentiation·C Giannini, C Bréchot
Mar 16, 2005·Journal of Virology·Belinda L HerringEric L Delwart
May 9, 2008·PloS One·Nathan A CannonUNKNOWN Virahep-C Study Group
Apr 12, 2011·Virology Journal·Usman A AshfaqSheikh Riazuddin
Apr 12, 2000·Journal of Viral Hepatitis·D B Smith
Oct 4, 2000·Reviews in Medical Virology·K L BarlowJ P Clewley
Oct 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M Pawlotsky
Nov 30, 2000·Current Infectious Disease Reports·M P Epstein, T Knox
Oct 31, 1998·Journal of Viral Hepatitis·J M Pawlotsky
Feb 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alan Lee RothmanUNKNOWN HALT-C Trial Group
Sep 20, 2012·Current Neurology and Neuroscience Reports·Micheline McCarthy, Melissa R Ortega
Jan 29, 2003·Journal of Virology·Wen YanYuqiao Shen
Mar 12, 2003·Journal of Medical Virology·Emanuele Durante MangoniPeter Karayiannis
Oct 13, 2016·World Journal of Gastroenterology : WJG·Camelia SultanaSimona Ruta
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S J PolyakD R Gretch
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T MurakamiC Sato
Jan 26, 2005·Avian Diseases·Alejandro BandaJohn El-Attrache
Aug 6, 2011·Scandinavian Journal of Gastroenterology·Christian M LangeChristoph Sarrazin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.